Meth makers to be foiled by jelly

Specialty drugmaker Highland Pharmaceuticals says it's found a way to halt the production of meth cookers. The St. Louis company has developed a chemical lock of sorts that prevents meth-makers from extracting the "API" pseudoephedrine from common cold and allergy drugs such as Sudafed and Mucinex. The new pseudoephedrine-making process turns the substance into an unusable, jelly-like material when drug-cookers try to extract it. Story

Sponsored By Digital Pharma Europe

Fierce Pharma Marketing is excited to announce the first virtual Digital Pharma Europe!

This summit will profile best-in-class case studies and senior-level discussions from leaders who are innovating the way we look at the intersection of digital technologies and marketing in Europe.